1. Home
  2. BIP vs ROIV Comparison

BIP vs ROIV Comparison

Compare BIP & ROIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Brookfield Infrastructure Partners LP

BIP

Brookfield Infrastructure Partners LP

HOLD

Current Price

$36.52

Market Cap

16.3B

ML Signal

HOLD

Logo Roivant Sciences Ltd.

ROIV

Roivant Sciences Ltd.

HOLD

Current Price

$22.05

Market Cap

15.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BIP
ROIV
Founded
2007
2014
Country
Bermuda
United Kingdom
Employees
N/A
N/A
Industry
Marine Transportation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
16.3B
15.8B
IPO Year
2008
N/A

Fundamental Metrics

Financial Performance
Metric
BIP
ROIV
Price
$36.52
$22.05
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
8
Target Price
$41.25
$24.31
AVG Volume (30 Days)
492.7K
5.9M
Earning Date
01-29-2026
02-06-2026
Dividend Yield
4.87%
N/A
EPS Growth
N/A
N/A
EPS
0.70
N/A
Revenue
$22,240,000,000.00
$20,329,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$741.42
P/E Ratio
$50.34
N/A
Revenue Growth
8.14
N/A
52 Week Low
$25.72
$8.73
52 Week High
$36.58
$23.91

Technical Indicators

Market Signals
Indicator
BIP
ROIV
Relative Strength Index (RSI) 67.38 47.48
Support Level $34.50 $22.28
Resistance Level $35.34 $23.11
Average True Range (ATR) 0.70 0.67
MACD 0.20 -0.15
Stochastic Oscillator 98.63 21.37

Price Performance

Historical Comparison
BIP
ROIV

About BIP Brookfield Infrastructure Partners LP

Brookfield Infrastructure Partners LP is a Bermuda exempted limited partnership that owns and operates quality, long-life assets that generate stable cash flows, by virtue of barriers to entry or other characteristics that tend to appreciate in value over time. It focuses on acquiring infrastructure assets that have low maintenance capital costs and high barriers to entry. The company's segments consist of Utilities, Transport, Midstream, and Data. Geographically, it generates maximum revenue from USA and also has a presence in Australia, Colombia, United Kingdom, Brazil, United States of America, Chile, Peru, and other countries.

About ROIV Roivant Sciences Ltd.

Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.

Share on Social Networks: